Webinar: When FL Changes: Understanding Progression & Transformation
Join us on March 27th for an informative webinar where expert clinicians and individuals living with FL come together to explore understanding the signs, treatment options, and what to expect.
Whether you’re navigating FL yourself, supporting or caring for a loved one, this session will provide vital knowledge, expert guidance, and a personal story of resilience. Connect with others through this engaging discussion and ask your questions.
Insights and Impact: The FLF at ASH Annual Meeting 2024, San Diego
The Follicular Lymphoma Foundation (FLF) was thrilled to participate in the recent American Society of Hematology (ASH) Annual Meeting.
Welcoming Emma France as FLF’s New Global CEO
The FLF welcomes Emma France as our new Global CEO. With over 20 years of non-profit leadership, Emma will help drive our mission forward with bold action and impactful change.
FLF’s CMO Shares Key Scientific Highlights from ASH 2024
FLF’s CMO highlights key takeaways from ASH 2024 on follicular lymphoma, from immunotherapy to new treatments.
World Cancer Day 2025: Supporting Follicular Lymphoma Patients
“Treat the person, not just the disease.”
World Cancer Day is on the 4th February. This year’s theme, United by Unique, emphasizes an essential shift in cancer care: putting patients at the heart of every decision.
2024 End of Year Reflections
This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.
Unlock the Cure Gala Dinner Raises Over £800,000
We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy.
Plain English Summary of the Publication:
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy.
Exploring the Future of Chemotherapy with Professor Jessica Okosun
Professor Jessica Okosun, FLF Scientific Advisor, answers your questions on chemotherapy-free options
Patient Survey Insights – Exploring FL Patient Experiences with Immunotherapy and Communication Preferences
Global patient survey results reveal key insights into patient perspectives on immunotherapy and information preferences